CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Wuhan Healthgen Biotechnology Corporation v. ExpressTec LLC

5:24-cv-04089

Overview

Case Number 5:24-cv-04089
Filing Date 2024-09-05
Status Litigation filed
Court District Court, D. Kansas (ksd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:01
Jury Demand Plaintiff

Parties

Defendant

InVitria, Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Ventria Bioscience Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

ExpressTec LLC Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Healthgen Biotechnology Co., Ltd. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Wuhan Healthgen Biotechnology Corporation Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. Kansas (ksd)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 1 proceeding
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): CN πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (1 found):
U.S. Courts: 1
U.S. District Court 2024-03-11
1:24-cv-00318

Wuhan Healthgen Biotechnology Corporation v. ExpressTec LLC

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9951100
Method for isolating and purifying recombinant human serum albumin from transgenic rice grain
Filed: 2015-04-01
Issued: 2018-04-24
Active (4.8 yrs remaining)
Expires: 2031-08-29
US10183984
Method for extracting recombinant human serum albumin from transgenic rice grain
Filed: 2016-01-14
Issued: 2019-01-22
Active (5.1 yrs remaining)
Expires: 2032-01-14
US10730926
Chromatographic method for isolating and purifying high-purity recombined human serum albumin
Filed: 2013-05-09
Issued: 2020-08-04
Active (6.5 yrs remaining) +19d PTA
Expires: 2033-05-28

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

32

Dispositive

13

Granted

2

Denied

1

Pending / Review

24

Motions by Category

Procedural / Extension Motion 12 Claim Construction / Markman Filing 5 Motion to Transfer Venue (28 U.S.C. Β§ 1404) 9 Motion to Compel Discovery 2 Motion for Summary Judgment (Rule 56) 3 Motion to Dismiss 1

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Rule 56) Pending / Under Review
MEMORANDUM AND ORDER. The Motion to Seal and Redact Invitria's Summary-Judgment (ECF 327 ) and Daubert (ECF 328 ) Replies is sustained (Doc. 335 ). On or be...
Entry #337 • 2026-02-04 Document →
Motion to Dismiss Pending / Under Review
Motion Hearing AND Order on Motion for Summary Judgment AND Order on Motion to Dismiss AND Order on Motion to Dismiss AND Order on Provisionally Sealed Motion A...
Entry #338 • 2026-02-04 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
MEMORANDUM AND ORDER. Invitria's Unopposed Motion to Redact Healthgen's Summary-Judgment (Doc. 307 ) and Daubert (Doc. 309 ) Responses and to Redact and Seal...
Entry #332 • 2026-01-27 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
MEMORANDUM AND ORDER. Invitria's Unopposed Motion to Seal InvitriaBatch Records and to Redact Memorandum in Support of Motion for Summary Judgment, Expert Repo...
Entry #305 • 2026-01-07 Document →
Motion to Transfer Venue (28 U.S.C. Β§ 1404) Granted
ORDER: The motion to transfer venue (D.I. 25 ) is GRANTED. The case is TRANSFERRED to the United States District Court for the District of Kansas. Signed by Jud...
Entry #57 • 2024-08-20 Document →
Motion to Transfer Venue (28 U.S.C. Β§ 1404) Granted
Minute Entry for proceedings held before Judge Richard G. Andrews - Motion Hearing held on 8/20/2024, regarding the Motion to Transfer Venue to the United State...
Entry #β€” • 2024-08-20

Docket Entries

(430 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against ExpressTec LLC, InVitria, Inc., and Ventria Bioscience Inc. ( Filing fee $ 405, receipt number ADEDC-4358159.) - filed by Wuhan Healthgen Biotechnology Corporation and Healthgen Biotechnology Co., Ltd. (Attachments: # 1 Exhibit 1-9, # 2 Civil Cover Sheet) [Transferred from Delaware on 9/5/2024.] (Entered: 03/11/2024)

Entry #1 • 2024-03-11
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) [Transferred from Delaware on 9/5/2024.] (Entered: 03/11/2024)

Entry #2 • 2024-03-11
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,951,100; 10,183,984; 10,730,926. (oam) [Transferred from Delaware on 9/5/2024.] (Entered: 03/11/2024)

Entry #3 • 2024-03-11
1

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Wuhan Healthgen Biotechnology Corporation. [Transferred from Delaware on 9/5/2024.] (Entered: 03/11/2024)

Entry #4 • 2024-03-11
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Wuhan Healthgen Biotechnology Corporation for Healthgen Biotechnology Co., Ltd. filed by Healthgen Biotechnology Co., Ltd. (oam) [Transferred from Delaware on 9/5/2024.] (Entered: 03/11/2024)

Entry #5 • 2024-03-11
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc